Biofarm (FRA:H3D) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 11, 2026)


FRA:H3D Biofarm SA FRA:H3D
69 GF Score
Price €0.24
GF Value €0.15
! 6 Warning Signs
View Full Analysis

What is Biofarm Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2026-07-11), Biofarm's Predictability Rank is 4.5-Stars. Biofarm's intrinsic value calculated from the Discounted Dividend model is €0.37 and current share price is €0.241. Consequently,

Biofarm's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is N/A.

FRA:H3D vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofarm Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Biofarm's Margin of Safety % (DCF Dividends Based) falls into.


FRA:H3D
69GF Score
Biofarm SA FRA:H3D
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofarm Margin of Safety % (DCF Dividends Based) Calculation

Biofarm's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(0.00-0.241)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Is Biofarm (FRA:H3D) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of €0.24 is trading 60.7% above its estimated GF Value™ of €0.15.

Key valuation signals for FRA:H3D:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €0.15 vs. price of €0.24 (60.7% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the FRA:H3D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofarm Business Description

Other Exchanges BIO:Romania
Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
69GF Score

Get the complete analysis for FRA:H3D

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.15
GF Value